-
Counselor attitudes toward contingency management for substance use disorder: Effectiveness, acceptability, and endorsement of incentives for treatment attendance and abstinence.
Aletraris L, Shelton JS, Roman PM. Counselor attitudes toward contingency management for substance use disorder: Effectiveness, acceptability, and endorsement of incentives for treatment attendance and abstinence. Journal of Substance Abuse Treatment 2015;57:41-48.
-
Measurement invariance of the short inventory of problems-revised across African-American and non-Latino white substance users.
Dillon FR, Whiteman K, Duan R. Measurement invariance of the short inventory of problems-revised across African-American and non-Latino white substance users. Journal of Ethnic & Cultural Diversity in Social Work 2015;24:109-129.
-
Pathways to change: Use trajectories following trauma-informed treatment of women with co-occurring post-traumatic stress disorder and substance use disorders.
Lopez-Castro T, Hu M, Papini S, Ruglass LM, Hien DA. Pathways to change: Use trajectories following trauma-informed treatment of women with co-occurring post-traumatic stress disorder and substance use disorders. Drug and Alcohol Review 2015;34(3):242-251.
-
Risk factors associated with HCV among opioid-dependent patients in a multisite study.
Schulte MT, Hser Y, Saxon AJ, Evans E, Li L, Huang D, Hillhouse MP, Thomas C, Ling W. Risk factors associated with HCV among opioid-dependent patients in a multisite study. Journal of Community Health 2015;40(5):940-947.
-
Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry.
Chartier KG, Sanchez K, Killeen TK, Burrow A, Carmody T, Greer TL, Trivedi MH. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. American Journal on Addictions 2015;24(4):336-340.
-
Alcohol screening among opioid agonist patients in a primary care clinic and an opioid treatment program.
Klimas J, Muench J, Wiest K, Croff R, Rieckmann TR, McCarty D. Alcohol screening among opioid agonist patients in a primary care clinic and an opioid treatment program. Journal of Psychoactive Drugs 2015;47(1):65-70.
-
NIDA Clinical Trials Network common data elements initiative: Advancing big-data addictive-disorders research [opinion].
Ghitza UE, Gore-Langton RE, Lindblad R, Tai B. NIDA Clinical Trials Network common data elements initiative: Advancing big-data addictive-disorders research [opinion]. Frontiers in Psychiatry 2015;6:33.
-
Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.
Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, Carroll KM. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug and Alcohol Dependence 2015;150:112-119.
-
Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs.
Killeen TK, Back SE, Brady KT. Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs. Drug and Alcohol Review 2015;34(3):234-241.
-
Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.
Luo SX, Covey LS, Hu M, Levin FR, Nunes EV, Winhusen TJ. Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers. American Journal on Addictions 2015;24(4):348-356.